STOPTHEBURN: Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees

Sponsor
Tulane University School of Medicine (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04347811
Collaborator
Spirit of Charity Foundation - University Medical Center (Other)
340
4
2
29.1
85
2.9

Study Details

Study Description

Brief Summary

Burnout affects a significant number of healthcare employees and leads to worsened mental health, increased job turnover, and patient safety events. Those caring for critically ill patients may be especially susceptible due to high patient mortality, long hours, and regular encounters with traumatic and ethical issues. Preliminary studies suggest that debriefing opportunities may reduce burnout through reflection on distressing patient events, enhancement of social support, and interprofessional collaboration. Death Cafés are a specific form of debriefing that focus on discussing death, dying, loss, and illness.

The purpose of this study is to evaluate whether biweekly Death Cafe group debriefing sessions can prevent burnout in ICU physicians and staff.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Death Cafe
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
340 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Systematic Trial Of PrevenTing Healthcare Employee Burnout: Using Reflection & Nourishment
Actual Study Start Date :
Jul 20, 2020
Actual Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Dec 23, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Death Cafe Arm

Participants undergo biweekly Death Café sessions hosted by a trained psychotherapist for 3 months.

Behavioral: Death Cafe
Death Cafés are a specific form of debriefing that focuses on discussing death, dying, loss, and illness. Nourishment in the form of cake is provided. These sessions may allow for reflection on distressing patient events while developing a sense of community and collaboration among hospital employees.

No Intervention: Control Arm

Participants do not undergo biweekly Death Café sessions hosted by a trained psychotherapist for 3 months.

Outcome Measures

Primary Outcome Measures

  1. Differences in Burnout as measured by the Maslach Burnout Inventory Score (MBI). [At the time of enrollment and at 1 month, 3 months, 6 months after enrollment]

    This is a validated 22-item, self-reported questionnaire that asks respondents to indicate on a 7 point Likert scale the frequency of certain feelings related to their job. Presence of burnout is defined by high values of depersonalization and emotional exhaustion with low values for personal accomplishment. Changes in mean scores between groups and within groups over time will be assessed.

Secondary Outcome Measures

  1. Differences in Depression as measured by the Patient Health Questionnaire 8 (PHQ-8) [At the time of enrollment and at 1 month, 3 months, 6 months after enrollment]

    This is an 8 question validated questionnaire that asks respondents to indicate the frequency with which they have experienced certain symptoms consistent with depression. Higher scores mean higher frequency of depression symptoms, and a score of 10 or higher will be considered to indicate clinically significant depression. Changes in mean scores between groups and within groups over time will be assessed.

  2. Differences in Anxiety as measured by the Generalized Anxiety Disorder 7 Scale (GAD-7) [At the time of enrollment and at 1 month, 3 months, 6 months after enrollment]

    This is a 7 question validated questionnaire that asks respondents to indicate the frequency with which they have experienced certain symptoms consistent with anxiety. Higher scores mean higher frequency of anxiety symptoms, and a score of 10 or higher will be considered to indicate clinically significant anxiety. Changes in mean scores between groups and within groups over time will be assessed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Physicians, nurses, pharmacists, or therapists working in the Intensive Care Unit and have worked for the full-time equivalent of at least 1 week in the preceding 4 weeks
Exclusion Criteria:
  • Not physicians, nurses, pharmacists, or therapists

  • Have worked less than the full-time equivalent of at least 1 week in the preceding 4 weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tulane Medical Center New Orleans Louisiana United States 70112
2 University Medical Center New Orleans Louisiana United States 70112
3 Children's Hospital New Orleans New Orleans Louisiana United States 70118
4 Ochsner Medical Center New Orleans Louisiana United States 70121

Sponsors and Collaborators

  • Tulane University School of Medicine
  • Spirit of Charity Foundation - University Medical Center

Investigators

  • Principal Investigator: Marjorie E Bateman, MD, Tulane University School of Medicine
  • Principal Investigator: Joshua Denson, MD, Tulane University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tulane University School of Medicine
ClinicalTrials.gov Identifier:
NCT04347811
Other Study ID Numbers:
  • 2019-908
First Posted:
Apr 15, 2020
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tulane University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022